Targeting Gardnerella Vaginalis with Jatamansin for the Treatment of Bacterial Vaginosis

Abstract:
One of the most prevalent infections in the vagina is bacterial vaginosis which causes immense physical and psychosocial discomfort in reproductive women and raises the possibility of preterm birth, pelvic inflammatory disease, and other conditions. Many studies show that among the bacterial species that cause this disease, Gardnerella vaginalis is the major cause of bacterial vaginosis. This study aims to identify potential protein targets for treating bacterial vaginosis disease using phytochemical compounds. The potential protein target of G. vaginalis is identified through several analyses using bioinformatics tools. It was interacted against the existing 74 phytochemical compounds which were already used in studies related to vaginal infection, G. vaginalis, bacterial vaginosis by using molecular docking approach and stable interactions were analyzed using MD simulation. The potential protein target is 30s ribosomal s15, and the top 5 potential phytochemical compounds are Luteolin, Paulowin, Jatamansin, Apigenin, and Kaempferol were identified, and their interactions were visualized. Molecular Dynamics shows that among the 5 compounds, Jatamansin is stable and interacts well with the target. Jatamansin is a potential phytochemical that interacts well and has good pharmacokinetic properties against the 30s ribosomal s15 G. vaginalis protein to inhibit bacterial vaginosis infection.
References:
[1]. Muzny,
C. A., Balkus, J., Mitchell, C., Sobel, J. D., Workowski, K., Marrazzo, J., et
al., 2022, Diagnosis and management of bacterial vaginosis: Summary of evidence
reviewed for the 2021 Centers for Disease Control and Prevention sexually
transmitted infections treatment guidelines, Clinical Infectious Diseases,
vol. 74, no. Supplement_2, pp. S144-51.
[2]. Vodstrcil,
L. A., Muzny, C. A., Plummer, E. L., Sobel, J. D., Bradshaw, C. S., 2021,
Bacterial vaginosis: Drivers of recurrence and challenges and opportunities in
partner treatment, BMC Medicine, vol. 19, no. 1, p. 194.
[3]. Sarkar,
P., Rifat, M. A., Talukdar, I. H., Saha, N., Rodriguez Neufeld, N. S., Miah, M.
I., et al., 2024, Self-reported urinary tract infection and bacterial vaginosis
symptoms among indigenous adolescents during seasonal periods of water
scarcity: A cross-sectional study in Bandarban Hill District of Bangladesh, Health
Science Reports, vol. 7, no. 5, p. e2107.
[4]. Peebles,
K., Velloza, J., Balkus, J. E., McClelland, R. S., Barnabas, R. V., 2019, High
global burden and costs of bacterial vaginosis: A systematic review and
meta-analysis, Sexually Transmitted Diseases, vol. 46, no. 5, pp.
304-11.
[5]. Nayak,
M., Sinha, S., Debta, A., Purohit, P., Patel, S., Patel, O., et al., 2020,
Prevalence and risk factors associated with bacterial vaginosis and candidiasis
in non-pregnant women of Western Odisha, India, Available from: https://imsear.searo.who.int/handle/123456789/214739.
[6]. Braunstein, M., Selk, A., 2024, Bacterial vaginosis, CMAJ, vol. 196,
no. 21, pp. E728.
[7]. Coudray,
M. S., Madhivanan, P., 2020, Bacterial vaginosis - A brief synopsis of the
literature, European Journal of Obstetrics & Gynecology and Reproductive
Biology, vol. 245, pp. 143-8.
[8]. Dong,
W., Wang, S., Wang, X., Xu, G., Liu, Q., Li, Z., et al., 2024, Characteristics
of vaginal microbiota of women of reproductive age with infections,
Microorganisms, vol. 12, no. 5, Available from: http://dx.doi.org/10.3390/microorganisms12051030.
[9]. Nuzhad,
A., Ghosh, B., Jana, S. C., 2023, Assessment of symptoms and risk factors as a
screening tool of bacterial vaginosis among reproductive age-group females in
West Bengal, India, Cureus, vol. 15, no. 10, p. e46310.
[10]. Chen,
X., Lu, Y., Chen, T., Li, R., 2021, The female vaginal microbiome in health and
bacterial vaginosis, Frontiers in Cellular and Infection Microbiology, vol. 11,
p. 631972.
[11]. Morrill,
S., Gilbert, N. M., Lewis, A. L., 2020, Gardnerella as a cause of bacterial
vaginosis: Appraisal of the evidence from models, Frontiers in Cellular and
Infection Microbiology, vol. 10, p. 168.
[12]. Ma, X.,
Wang, X., Ye, S., Liu, J., Yuan, H., Wang, N., 2022, Biofilm and pathogenic
factor analysis of Gardnerella associated with bacterial vaginosis in Northeast
China, Frontiers in Microbiology, vol. 13, p. 1033040.
[13]. Filloux,
A., 2010, Secretion signal and protein targeting in bacteria: A biological
puzzle, Journal of Bacteriology, vol. 192, no. 15, pp. 3847-9.
[14]. Hurdle,
J. G., O’Neill, A. J., Chopra, I., Lee, R. E., 2011, Targeting bacterial
membrane function: An underexploited mechanism for treating persistent
infections, Nature Reviews Microbiology, vol. 9, no. 1, pp. 62-75.
[15]. Jiao,
L., Liu, Y., Yu, X. Y., Pan, X., Zhang, Y., Tu, J., et al., 2023, Ribosome
biogenesis in disease: New players and therapeutic targets, Signal
Transduction and Targeted Therapy, vol. 8, no. 1, p. 15.
[16]. Hurtado-Rios, J. J., Carrasco-Navarro, U., Almanza-Pérez, J. C.,
Ponce-Alquicira, E., 2022, Ribosomes: The new role of ribosomal proteins as
natural antimicrobials, International Journal of Molecular Sciences,
vol. 23, no. 16, p. 9123.
[17]. National
Center for Biotechnology Information [Internet]. [cited 2024 Jul 23]. Available
from: www.ncbi.nlm.nih.gov/.
[18]. Gabler,
F., Nam, S. Z., Till, S., Mirdita, M., Steinegger, M., Söding, J., et al.,
2020, Protein sequence analysis using the MPI bioinformatics toolkit, Current
Protocols in Bioinformatics, vol. 72, no. 1, p. e108.
[19]. PDBsum
Generate [Internet]. [cited 2024 Jul 23]. Available from: https://www.ebi.ac.uk/thornton-srv/databases/pdbsum/Generate.html.
[20]. Xu, D.,
Zhang, Y., 2011, Improving the physical realism and structural accuracy of
protein models by a two-step atomic-level energy minimization, Biophysical
Journal, vol. 101, no. 10, pp. 2525-34.
[21]. Karp,
P. D., Paley, S., Caspi, R., Kothari, A., Krummenacker, M., Midford, P. E., et
al., 2023, The EcoCyc database, EcoSal Plus, Available from: https://journals.asm.org/doi/10.1128/ecosalplus.esp-0002-2023.
[22]. PrankWeb
[Internet]. [cited 2024 Jul 23]. Available from: https://prankweb.cz/.
[23]. Krivák,
R., Hoksza, D., 2018, P2Rank: Machine learning-based tool for rapid and
accurate prediction of ligand binding sites from protein structure, Journal
of Cheminformatics, vol. 10, no. 1, p. 1-12.
[24]. UCSF
Chimera Home Page [Internet]. [cited 2024 Jul 23]. Available from: http://www.cgl.ucsf.edu/chimera.
[25]. PubMed
[Internet]. [cited 2024 Jul 23]. PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/.
[26]. Google
Scholar [Internet]. Available from: https://scholar.google.com/schhp?hl=en&as_sdt=0,5.
[27]. USDA
Phytochemical Database [Internet]. [cited 2024 Jul 23]. Available from: https://phytochem.nal.usda.gov/.
[28]. Daina,
A., Michielin, O., Zoete, V., 2017, SwissADME: A free web tool to evaluate
pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of small
molecules, Scientific Reports, vol. 7, no. 1, p. 1-13.
[29]. ProTox-3.0
- Prediction of TOXicity of Chemicals [Internet]. [cited 2024 Jul 23].
Available from: https://tox.charite.de/protox3/.
[30]. Kim,
S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., et al., 2022, PubChem
2023 update, Nucleic Acids Research, vol. 51, no. D1, pp. D1373-80.
[31]. BIOVIA Discovery Studio [Internet]. Available from: http://accelrys.com/products/collaborative-science/biovia-discovery-studio/.
[32]. PyRx Website [Internet]. [cited 2024 Jul 23]. Available from: http://pyrx.sourceforge.net.
[33]. Nardostachys jatamansi essential oil, 2023, Antioxidant capacity and
combinatorial antimicrobial effects against drug-resistant bacteria, Current
Research in Biotechnology, vol. 5,
p. 100118.
[34]. Geethashree, S., Murthy, I. A. S., Bagchi, P., 2023,
Establishing the taxa with phylogenetic profile and in-silico Ayurvedic remedy
of microbiome of bacterial vaginosis, Advances in Health Sciences Research, pp. 178-200.
[35]. Marín, E., Haesaert, A., Padilla, L., Adán, J.,
Hernáez, M. L., Monteoliva, L., et al., 2018, Unraveling Gardnerella
vaginalis surface proteins
using cell shaving proteomics, Frontiers in Microbiology, vol. 9, p. 355414.
[36]. Shvartsman, E., Hill, J. E., Sandstrom, P., MacDonald, K. S., 2023, Gardnerella revisited: Species heterogeneity, virulence factors, mucosal immune responses, and contributions to bacterial vaginosis, Infection and Immunity, vol. 91, no. 5, p. e0039022.